Sales Growth YoY (Last 12 Months): Tango Therapeutics (TNGX)

Public company logo of Tango Therapeutics Corp (TNGX)

Tango Therapeutics is developing a biopharmaceutical environment for targeted oncology by creating unique patented solutions. The year-over-year sales trend over a 12-month period clearly demonstrates the current dynamics, where -99.70 is recorded as the baseline value. Tango Therapeutics focuses on precision small molecules for complex types of cancer, funding extensive R&D expenses through its existing cash reserves.

Tango Therapeutics, Inc. (TNGX) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/18/2026

Tango Therapeutics, Inc. (TNGX) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Tango Therapeutics
Product sample of tangotx.com

This indicator measures revenue dynamics over the last twelve months, allowing investors to assess the current pace of business scaling and the company's operational resilience. By analyzing the trailing twelve-month revenue growth chart, one can determine how effectively the implementation of functional genomics into targeted cancer therapy converts into actual revenue, confirming the fundamental viability of the high-tech model of Tango Therapeutics (TNGX).

Competitors of Tango Therapeutics (TNGX)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) IOVA|IMTX - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) XNCR (Xencor Corp)|Revenue Change YoY (Last 12 Months) CMPX|Sales Growth YoY (TTM) REPL (Replimune)|Revenue Dynamics YoY (Last Twelve Months) LYEL|innate-pharma.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Pyxis Oncology|Compugen Limited (CGEN) - Sales Growth YoY (Last Twelve Months)|IO Biotech, Inc. - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)